We evaluated the effect of treatment of gonorrhea on simultaneous Chlamydia trachomatis infection by randomly assigning 293 heterosexual men and 246 heterosexual women with gonorrhea to receive one of the following treatment regimens: (1) 4.8 million units of aqueous procaine penicillin plus 1 g of probenecid, (2) nine tablets of trimethoprim-sulfamethoxazole daily for three days, or (3) 500 mg of tetracycline four times a day for five days. Among the men, gonococcal infection was cured in 99 per cent given penicillin plus probenecid, 96 per cent given trimethoprim-sulfamethoxazole, and 98 per cent given tetracycline. Among the women, only 90 per cent given tetracycline were cured, in contrast to 97 per cent given penicillin plus probenecid and 99 per cent given trimethoprim-sulfamethoxazole. Chlamydial infection, present in 15 per cent of the men and 26 per cent of the women, was cured in 30 of 32 patients given trimethoprim-sulfamethoxazole and 27 of 29 given tetracycline, but in only 10 of 23 given penicillin plus probenecid. Among chlamydia-positive patients, postgonococcal urethritis in men and cervicitis in women occurred more often in patients given penicillin plus probenecid. Salpingitis developed in 6 of 20 women given penicillin plus probenecid, but in only 1 of 26 given trimethoprim-sulfamethoxazole and in none of 24 given tetracycline. We conclude that the use of penicillin plus probenecid alone for gonorrhea in heterosexual patients carries an unacceptably high risk of postgonococcal chlamydial morbidity. Trimethoprim-sulfamethoxazole and tetracycline were highly effective against both pathogens and were well tolerated in men, but both drugs caused frequent side effects in women. The failure of tetracycline to cure gonorrhea in 10 per cent of women argues against its use alone; treatment with penicillin followed by tetracycline has been recommended for further trial.
This article has been cited by other articles:
Blake, D. R., Lemay, C. A., Indurkhya, A.
(2007). Correlates of Readiness to Receive Chlamydia Screening Among 2 Populations of Youths. Arch Pediatr Adolesc Med
161: 1088-1094
[Abstract][Full Text]
O'Connell, C. M., Ingalls, R. R., Andrews, C. W. Jr., Scurlock, A. M., Darville, T.
(2007). Plasmid-Deficient Chlamydia muridarum Fail to Induce Immune Pathology and Protect against Oviduct Disease. J. Immunol.
179: 4027-4034
[Abstract][Full Text]
Fung, M., Scott, K. C, Kent, C. K, Klausner, J. D
(2007). Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex. Transm. Infect.
83: 304-309
[Abstract][Full Text]
Adams, E. J, Turner, K. M E, Edmunds, W J., Roberts, T E, Low, N, Adams, E. J, Edmunds, W J., Turner, K. M E
(2007). The cost effectiveness of opportunistic chlamydia screening in England. Sex. Transm. Infect.
83: 267-275
[Abstract][Full Text]
Low, N, Egger, M, Sterne, J A C, Harbord, R M, Ibrahim, F, Lindblom, B, Herrmann, B
(2006). Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study.. Sex. Transm. Infect.
82: 212-218
[Abstract][Full Text]
Bernstein, K. T., Mehta, S. D., Rompalo, A. M., Erbelding, E. J.
(2006). Cost-Effectiveness of Screening Strategies for Gonorrhea Among Females in Private Sector Care.. Obstet Gynecol
107: 813-821
[Abstract][Full Text]
Hu, D., Hook, E. W. III, Goldie, S. J.
(2004). Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis. ANN INTERN MED
141: 501-513
[Abstract][Full Text]
Wyrick, P. B., Knight, S. T.
(2004). Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J Antimicrob Chemother
54: 79-85
[Abstract][Full Text]
van Valkengoed, I. G., Morre, S. A, van den Brule, A. J., Meijer, C. J., Bouter, L. M, Boeke, A J. P
(2004). Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses. Int J Epidemiol
33: 416-425
[Abstract][Full Text]
Lyss, S. B., Kamb, M. L., Peterman, T. A., Moran, J. S., Newman, D. R., Bolan, G., Douglas, J. M. Jr., Iatesta, M., Malotte, C K., Zenilman, J. M., Ehret, J., Gaydos, C., Newhall, W. J., for the Project RESPECT Study Group*,
(2003). Chlamydia trachomatis among Patients Infected with and Treated for Neisseria gonorrhoeae in Sexually Transmitted Disease Clinics in the United States. ANN INTERN MED
139: 178-185
[Abstract][Full Text]
Low, N., Egger, M.
(2002). What should we do about screening for genital chlamydia?. Int J Epidemiol
31: 891-893
[Full Text]
Zhang, W., Cohenford, M., Lentrichia, B., Isenberg, H. D., Simson, E., Li, H., Yi, J., Zhang, D. Y.
(2002). Detection of Chlamydia trachomatis by Isothermal Ramification Amplification Method: a Feasibility Study. J. Clin. Microbiol.
40: 128-132
[Abstract][Full Text]
Mangione-Smith, R., McGlynn, E. A., Hiatt, L.
(2000). Screening for Chlamydia in Adolescents and Young Women. Arch Pediatr Adolesc Med
154: 1108-1113
[Abstract][Full Text]
Simms, I, Stephenson, J M
(2000). Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?. Sex. Transm. Infect.
76: 80-87
[Full Text]
Kelly, K. A., Walker, J. C., Jameel, S. H., Gray, H. L., Rank, R. G.
(2000). Differential Regulation of CD4 Lymphocyte Recruitment between the Upper and Lower Regions of the Genital Tract during Chlamydia trachomatis Infection. Infect. Immun.
68: 1519-1528
[Abstract][Full Text]
Cohen, D. A., Nsuami, M., Martin, D. H., Farley, T. A.
(1999). Repeated School-based Screening for Sexually Transmitted Diseases: A Feasible Strategy for Reaching Adolescents. Pediatrics
104: 1281-1285
[Abstract][Full Text]
Shafer, M.-A. B., Pantell, R. H., Schachter, J.
(1999). Is the Routine Pelvic Examination Needed With the Advent of Urine-Based Screening for Sexually Transmitted Diseases?. Arch Pediatr Adolesc Med
153: 119-125
[Abstract][Full Text]
Darville, T.
(1998). Chlamydia. Pediatr. Rev.
19: 85-91
[Full Text]
Dean, D, Ferrero, D, McCarthy, M
(1998). Comparison of performance and cost-effectiveness of direct fluorescent- antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection [In Process Citation]. J. Clin. Microbiol.
36: 94-99
[Abstract][Full Text]
Cohen, D. A., Nsuami, M., Etame, R. B., Tropez-Sims, S., Abdalian, S., Farley, T. A., Martin, D. H.
(1998). A School-based Chlamydia Control Program Using DNA Amplification Technology. Pediatrics
101
: e1-e1
[Abstract][Full Text]
Johnson, A. M, Grun, L., Haines, A.
(1996). Controlling genital chlamydial infection. BMJ
313: 1160-1161
[Full Text]
McCormack, W. M.
(1994). Pelvic Inflammatory Disease. NEJM
330: 115-119
[Full Text]
